Firstsource’s Post

In a highly competitive Medicare market, it is essential to have a deep understanding of your clients. This includes their health condition, preferred healthcare providers, prescription drug requirements, budget considerations, desired additional benefits, plan ratings, and coverage choices. By gaining insight into your customers' profiles and healthcare preferences, you can effectively steer them towards the most suitable plan that aligns with their individual needs. Keeping abreast of industry trends and arming yourself with information will enable you to assist your clients in making well-informed decisions amidst the crowded Medicare landscape. #ClientCare #StayInformed #PlanChoices

Formularies, contracts, and rebates have created roadblocks for biosimilars. While these drugs offer significant cost savings, outdated PBM structures slow their adoption. It's time to rethink our approach to ensure access and affordability for patients. 💊💡 #Biosimilars #PBMReform #HealthcareSavings #PharmacyBenefitManagement #PatientAccess #Education #CPBS #PBIA #TransparentRx

Understanding Medigap vs Advantage Plans: Hidden Costs Revealed! Explore the essential differences between Medigap and Advantage plans in this informative video! Learn about prescription drug coverage, additional costs, and how to tailor your healthcare plans for your needs. Keep your health and finances in check with this crucial comparison. #Medigap #AdvantagePlans #HealthcareCoverage #PrescriptionDrugs #HealthInsurance #SeniorHealth #InsuranceCosts #Medicare #HealthTips #FinancialPlanning

Formularies, contracts, and rebates have created roadblocks for biosimilars. While these drugs offer significant cost savings, outdated PBM structures slow their adoption. It's time to rethink our approach to ensure access and affordability for patients. 💊💡 #Biosimilars #PBMReform #HealthcareSavings #PharmacyBenefitManagement #PatientAccess #Education #CPBS #PBIA #TransparentRx

Formularies, contracts, and rebates have created roadblocks for biosimilars. While these drugs offer significant cost savings, outdated PBM structures slow their adoption. It's time to rethink our approach to ensure access and affordability for patients. 💊💡 #Biosimilars #PBMReform #HealthcareSavings #PharmacyBenefitManagement #PatientAccess #Education #CPBS #PBIA #TransparentRx

Formularies, contracts, and rebates have created roadblocks for biosimilars. While these drugs offer significant cost savings, outdated PBM structures slow their adoption. It's time to rethink our approach to ensure access and affordability for patients. 💊💡 #Biosimilars #PBMReform #HealthcareSavings #PharmacyBenefitManagement #PatientAccess #Education #CPBS #PBIA #TransparentRx

Employers, a friendly reminder: The deadline to submit your RxDC report to CMS is June 1, 2024, for the 2023 data period. This crucial report details your group health plans' prescription drug and healthcare expenses. Good news! Most of our carriers are proactively handling this submission for their clients, and they may reach out to you for the necessary data. Please coordinate with your issuers, TPAs, or PBMs to ensure this process is seamless. For those with self-insured plans, remember you bear the ultimate responsibility for compliance. Start preparing now to ensure a hassle-free submission. #HealthcareReporting #RxDCReport #CMS #EmployeeBenefits

Big pharma is getting sued! Is that really a surprise to anyone? As the cost of prescription medicine continues to rise, we ask ourselves "Why"? I think this lawsuit will provide some answers. Why do drugs really cost as much as they do? Why are hospitals allowed to mark up drugs 5 to 10 times their value before they are delivered to a patient? Why are physicians also allowed to markup drugs administered at their offices 5 to 10 times their acquisition cost? I'll tell you why, because insurance companies and PBM's allow them to do so and get paid and it fits the "allowable charges" negotiated for you. It needs to stop. Why is it "illegal" to source the same drugs from Canada that are far less expensive? Because the FDA wants it that way. Read the article and mark your calendars, it's time for a change if you're ready! #rxprofits #rxmarkup #wholsalerx #hubinternational #rxcarveout

🌍 Across the globe, healthcare systems are continuously evolving to balance innovation with affordability. In the last year, significant strides have been made in regulating prescription drug pricing and reimbursement to ensure cutting-edge treatments remain within reach for those needing them most. 🏥💡 These changes underscore a global commitment to making healthcare more accessible, equitable, and financially sustainable. At PVS Partners, we wish to play our part in helping our friends stay informed with a series of one-pager country updates as we navigate these changes together. #HealthcareInnovation #DrugPricing #GlobalHealthPolicy #PVSPartners

🌍 Across the globe, healthcare systems are continuously evolving to balance innovation with affordability. In the last year, significant strides have been made in regulating prescription drug pricing and reimbursement to ensure cutting-edge treatments remain within reach for those needing them most. 🏥💡 These changes underscore a global commitment to making healthcare more accessible, equitable, and financially sustainable. At PVS Partners, we wish to play our part in helping our friends stay informed with a series of one-pager country updates as we navigate these changes together. #HealthcareInnovation #DrugPricing #GlobalHealthPolicy #PVSPartners